Subcutaneous Administration of Carbidopa Enhances Oral Levodopa Pharmacokinetics: A Series of Studies Conducted in Pigs, Mice, and Healthy Volunteers-Reference-Cited by-同舟云学术

Subcutaneous Administration of Carbidopa Enhances Oral Levodopa Pharmacokinetics: A Series of Studies Conducted in Pigs, Mice, and Healthy Volunteers

Published:2019-06-13 Issue:4 Volume:42 Page:111-116
ISSN:1537-162X
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:Clin Neuropharm

Author:

Shaltiel-Karyo Ronit,Caraco Yoseph,Zawaznik Eduardo,Weinstock Irena,Nemas Mara,Oren Sheila,Yacoby-Zeevi Oron,LeWitt Peter A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference23 articles.

1. The site of dopamine formation in rat striatum after L-dopa administration;J Pharmacol Exp Ther,1981

2. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa;Ann Neurol,1997

3. Carbidopa in Parkinson disease and in nausea and vomiting of levodopa;Arch Neurol,1974

4. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers;Eur Neurol,1987

5. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism;Ann Neurol,1985

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program;Frontiers in Neurology;2022-11-10

2. Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease;Neurology;2022-06-15

3. Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study;Journal of Parkinson's Disease;2021-02-02